Tianning Zou
Overview
Explore the profile of Tianning Zou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun J, Tan J, Zheng H, Jiang J, Zou T, Li H, et al.
Med Sci Monit
. 2022 Nov;
28:e938619.
PMID: 36447408
BACKGROUND Reproductive period for women, begins at menarche and ends at menopause, which represented the total time period of exposure to cycling reproductive hormones. The potential associations between clinicopathological features...
2.
Kong X, Zhang Q, Wu X, Zou T, Duan J, Song S, et al.
Front Oncol
. 2022 Jun;
12:816297.
PMID: 35669440
Neoadjuvant chemotherapy (NAC) is increasingly widely used in breast cancer treatment, and accurate evaluation of its response provides essential information for treatment and prognosis. Thus, the imaging tools used to...
3.
Li Z, Zhang J, Zou W, Xu Q, Li S, Wu J, et al.
PLoS One
. 2021 Jul;
16(7):e0254267.
PMID: 34242313
Methylenetetrahydrofolate reductase (MTHFR), a folate-dependent enzyme, is reportedly involved in several cancer types. The MTHFR C677T polymorphism influences many biological processes, including tumorigenesis. However, the association between the MTHFR C677T...
4.
Tang S, Zheng K, Tang Y, Li Z, Zou T, Liu D
J Biosci
. 2019 Jun;
44(2).
PMID: 31180050
To investigate the source of serum exosomal HOTAIR, to uncover the diagnostic and prognostic values of serum exosomal HOTAIR, and to discern the expression of serum exosomal HOTAIR between neoadjuvant...
5.
Liu R, Zhi X, Zhou Z, Zhang H, Yang R, Zou T, et al.
Sci Rep
. 2018 Jan;
8(1):1138.
PMID: 29348684
As the most malignant breast cancer subtype, triple-negative breast cancer (TNBC) does not have effective targeted therapies clinically to date. As a selective Sp1 inhibitor, Mithramycin A (MIT) has been...
6.
Yang Z, Huang S, Wang J, Xi Y, Yang X, Tang Q, et al.
Sci Rep
. 2017 Mar;
7(1):80.
PMID: 28250439
Breast cancer-related lymphoedema (BCRL) is a common and intractable complication. To evaluate the possible complications of using lymphatic transverse rectus abdominis myocutaneous/deep inferior epigastric perforator (TRAM/DIEP) flaps for breast reconstruction...
7.
Li Z, Dong J, Zou T, Du C, Li S, Chen C, et al.
Oncotarget
. 2016 Dec;
8(7):11555-11565.
PMID: 28030791
Purpose: Dexamethasone (Dex), a glucocorticoid (GC), is used as a pretreatment drug in cancer patients undergoing chemotherapy. Dex functions by binding to the glucocorticoid receptor (GR) to prevent allergic reactions...
8.
Wu X, Xu W, Zhou T, Cao N, Ni J, Zou T, et al.
Int J Mol Sci
. 2016 Jun;
17(7).
PMID: 27347936
Folate-mediated one-carbon metabolism (FMOCM) is linked to DNA synthesis, methylation, and cell proliferation. Vitamin B6 (B6) is a cofactor, and genetic polymorphisms of related key enzymes, such as serine hydroxymethyltransferase...
9.
Wang K, Ren Y, Li H, Zheng K, Jiang J, Zou T, et al.
PLoS One
. 2016 Apr;
11(3):e0152312.
PMID: 27031236
The incidence of young cases of breast cancer is higher in China compared to the western world. We aimed to explore differences in risk factors, clinicopathological features and treatment modes...
10.
Ge F, Chen W, Qin J, Zhou Z, Liu R, Liu L, et al.
Oncotarget
. 2015 Jun;
6(25):21369-78.
PMID: 26079537
The Krüppel-like factor 5 (KLF5) has been suggested to promote breast cell proliferation, survival and tumorigenesis. KLF5 protein degradation is increased by several E3 ubiquitin ligases, including WWP1 and SCFFbw7,...